Company / Operating Cash Flow
Stryker Corporation Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$5.0B
FY2025
5-year range
$3.3B / $5.0B
FY2021-FY2025
Trend
+18.9%
vs FY2024
Sector context
#10 of 164
Health Care
What the data says
Among 164 Health Care companies, Stryker Corporation is in the top 6% for operating cash flow. Operating Cash Flow has fluctuated over the past 10 years, ranging from $981M in FY2017 to $5.0B in FY2025.
Based on SEC 10-K filings.
$5.0B in FY2025 with a 5-year CAGR of +14.1%. Top quartile in the Health Care sector.
Improved from $3.3B to $5.0B over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +15.5%
- 5-Year CAGR
- +14.1%
- 10-Year CAGR
- -
Sector benchmark
+383.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +14.1%, indicating consistent growth.
- In FY2025, operating cash flow increased 18.9% year-over-year.
- Ranks #10 out of 164 companies in the Health Care sector.
- Lowest operating cash flow in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.0B | +18.9% |
| FY2024 | $4.2B | +30.0% |
| FY2023 | $3.3B | -0.4% |
| FY2022 | $3.3B | +0.4% |
| FY2021 | $3.3B | +25.0% |
| FY2020 | $2.6B | +67.4% |
| FY2019 | $1.6B | -18.6% |
| FY2018 | $1.9B | +95.2% |
| FY2017 | $981.0M | -44.9% |
| FY2016 | $1.8B | +81.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026